Month: April 2021

We are very pleased to present our new website to you.

IT-Choice Software AG’s new homepage is now live at the familiar address.

In addition to a modern design, the redesign focused primarily on adapting the content to our current projects and our vision for the future.

We also wanted to make it easier for our partners, customers, and job applicants to navigate the site and find all the information they need. You may also find inspiration through our products and services.

On our News page, we also provide updates on company news, products, and events.

We hope you enjoy exploring our website.

Of course, we welcome your feedback and are just as grateful for suggestions and comments as we are for praise or criticism.

Please feel free to use our contact form for this purpose.

Dear customers, partners, and friends of IT-Choice,

2020 was unique and challenging in every respect.

In this unusual time, we were given the opportunity to contribute our previous experience with medical registries to a new project: the vaccination documentation system for the state of Rhineland-Palatinate.

Within just a few weeks, we developed and rolled out statewide the standardised system IDSTAR (ID = vaccination documentation) for vaccination appointment scheduling, the registration and documentation of COVID-19 vaccinations in vaccination centres, and the transfer of data to the Robert Koch Institute for Digital Vaccination Rate Monitoring (DIM).

The IDSTAR system is based on our STARKIT product and can therefore be adapted in a short time to the frequently changing requirements in a dynamic project environment.

In particular, the ability to freely configure all forms, analysis tools and interfaces gave us the necessary speed to build the system.

Thanks to the close and highly efficient collaboration with our client, our agile software development based on Scrum, and our dedicated employees, this important project implementation was possible on a very tight schedule.

We are very pleased that we can make a contribution to the fight against the SARS-CoV-2 virus.